01—Abstract
Summary
Summary of the 10-Q filed April 23, 2025. Cited figures are marked; the original filing is the authoritative source.
Quest Diagnostics Inc. (DGX) reported its first quarter 2025 results with a notable increase in net revenues, primarily driven by recent acquisitions and organic growth within its Diagnostic Information Services (DIS) segment.
Net revenues grew by 12.1% year-over-year, reaching $2.65 billiona. The company demonstrated improved operating income and net income, with diluted earnings per share (EPS) rising to $1.94 from $1.72 in the prior year's quarter. Cash flow from operations saw a significant increase, highlighting improved working capital management and higher operating income.
While the company repaid $600 millionb in senior notes, it also utilized its secured receivables credit facility for new borrowings. Management remains confident in the company's liquidity and ability to fund future operations, capital expenditures, and growth initiatives.
02—Key points
Key Highlights
- Net revenues increased by 12.1% to $2.65 billion in Q1 2025, driven by a 12.7% rise in DIS revenues, largely due to recent acquisitions contributing approximately 10% to DIS revenue.
- Requisition volume increased by 12.4%, with acquisitions contributing 13.3%, while organic volume slightly decreased by 0.9%.
- Revenue per requisition saw a modest increase of 0.3% year-over-year, influenced by an increase in tests per requisition, though partially offset by acquisitions with lower revenue per requisition.
- Operating income grew by 15.4% to $346 million, and net income attributable to Quest Diagnostics increased by 13.2% to $220 million.
- Diluted earnings per share (EPS) rose to $1.94 in Q1 2025, up from $1.72 in Q1 2024, reflecting improved profitability.
- Net cash provided by operating activities significantly increased to $314 million from $154 million in the prior year period, indicating improved cash generation.
- The company repaid $600 million in senior notes that matured in March 2025 and also borrowed $215 million under its secured receivables credit facility.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q1 FY2025, Quest Diagnostics Inc kept $0.08.
- Revenue$2.65B100.0%
- Cost of revenue−$1.79B67.5%
- Gross profit$863.0M32.5%
- Operating costs−$517.0M19.5%
- Operating income$346.0M13.0%
- Interest, other & tax−$126.0M4.8%
- Net income$220.0M8.3%
04—Financials
Financial Highlights
Figures from 10-QQ1 FY2025filed April 23, 2025Financial Statements
Q1 FY2025 against Q1 FY2024
| Line item | Q1 FY2025Q1 FY2024 | Change |
|---|---|---|
| Revenue | $2.65B$2.37B | +12.1% |
| Cost of Revenue | $1.79B$1.59B | +12.2% |
| Gross Profit | $863.00M$771.00M | +11.9% |
| SG&A Expenses | $476.00M$440.00M | +8.2% |
| Operating Expenses | $2.31B$2.07B | +11.6% |
| Operating Income | $346.00M$300.00M | +15.3% |
| Net Income | $220.00M$194.00M | +13.4% |
| EPS (Basic) | $1.97$1.74 | +13.2% |
| EPS (Diluted) | $1.94$1.72 | +12.8% |
| Shares Outstanding (Basic) | 111.00M111.00M | 0.0% |
| Shares Outstanding (Diluted) | 113.00M112.00M | +0.9% |
05—Questions
Frequently Asked Questions
What drove the significant increase in net revenues for Quest Diagnostics in the first quarter of 2025?
The substantial increase in net revenues was primarily driven by the impact of recent acquisitions, which contributed significantly to the Diagnostic Information Services (DIS) segment's revenue. Organic growth also played a role, though acquisitions were the larger contributor.
How did the company manage its debt obligations during the quarter?
Quest Diagnostics repaid its $600 million in senior notes that matured in March 2025. To manage liquidity and fund operations, the company also borrowed $215 million under its secured receivables credit facility.
What is the outlook for cash flow from operations?
The company reported a strong increase in net cash provided by operating activities, rising to $314 million from $154 million in the prior year's quarter. This improvement was attributed to the timing of payments and increased operating income, suggesting a positive trend in cash generation.
Are there any significant changes in the company's strategic initiatives or programs mentioned in the report?
The company continues to focus on its 'Invigorate' program, which aims to drive cost savings and productivity improvements across its operations through automation and AI. The report also mentions a multi-year project called 'Project Nova' to modernize its 'Order-to-Cash' business processes.
06—Continue